Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| RXRX (Recursion Pharmaceuticals, Inc.) | -19.07% | -27.57% | -26.77% | -34.62% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 04/20/2021
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| RXRX (Recursion Pharmaceuticals, Inc.) | 04/20/2021 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -7.80 | -27.57 | -26.77 | -34.62 | NA | NA | NA | … | … | -19.07 | -37.13 | -25.05 | 27.89 | -54.99 | -42.79 |
| Sharpe Ratio | NA | -0.30 | -0.33 | -0.39 | NA | NA | NA | … | … | -0.48 | -0.45 | -0.37 | 0.24 | -0.61 | -0.60 |
| Standard Deviation(%) | NA | 72.23 | 89.92 | 90.04 | NA | NA | NA | … | … | 61.97 | 89.85 | 86.81 | 101.08 | 92.63 | 91.28 |
| Draw Down(%) | NA | 58.17 | 82.09 | 93.13 | NA | NA | NA | … | … | 42.74 | 64.58 | 63.27 | 67.91 | 72.05 | 60.95 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 04/20/2021
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RXRX (Recursion Pharmaceuticals, Inc.) |
-40.99%
Jun 2021 – Jun 2024 |
-32.88%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RXRX (Recursion Pharmaceuticals, Inc.) |
-3.39%
Apr 2022 – Apr 2025 |
-32.88%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart